Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP compliant OECD guideline study, available as unpublished report, no restrictions, fully adequate for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2001
Report date:
2001

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Fatty acids, tall-oil, reaction products with diethylenetriamine
EC Number:
263-160-2
EC Name:
Fatty acids, tall-oil, reaction products with diethylenetriamine
Cas Number:
61790-69-0
Molecular formula:
Monoamides: C22H43N3O / C22H45N3O Diamides: C40H73N3O2 / C40H75N3O2 / C40H77N3O2
IUPAC Name:
Amidation products of tall-oil fatty acids with diethylenetriamine
Details on test material:
- Name of test material (as cited in study report): INTERMEDIO UB 2
- Substance type: UVCB
- Physical state: solid, light yellow mass
- Lot/batch No.: 11 C 071

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- SPF-Wistarrats strain Winkelmann, Paderborn
- Mean weight males: 220 - 230 g
- Mean weight females: 190 - 210 g
- Fasting period before study: 16 hours
- Housing: 3 animals per sex per cage, randomly divided in single cages
- Diet: laboratory standard diet (Altromin, Lage), ad libitum
- Water: ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature: 22.5 ± 2.5 °C
- Humidity: 40 - 60 %
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Details on oral exposure:
The test substance was warmed at 60 °C and suspended in olive oil with help of ULTRATURRAX and some drops of Tween 80.
Administration by oral gavage, using a non-flexible stomach tube.
Doses:
Group 1: 2000 mg/kg/bw (10 p.c.)
Group 2: 4000 mg/kg/bw (20 p.c.)
Frequency: single dosage, on day 1
No. of animals per sex per dose:
3 animals per dose/sex
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 24 h, 7 and 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, macroscopic organ changes
Statistics:
No statistical analysis was performed (The method used is not intended to allow the calculation of a precise LD50 value).

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 4 000 mg/kg bw
Mortality:
No mortalities occured.
Clinical signs:
other: No clinical signs of systemic toxicity were noted.
Gross pathology:
No clear pathologic findings did occur in final autopsy in any of big body cavities and no pathological changes macroscopically could be observed which were due to the test procedure or the test compound.
Other findings:
None

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The oral LD50 value of INTERMEDIO UB 2 in Wistar rats was established to exceed 4000 mg/kg body weight.
Based on these results and according to the EC criteria for classification and labelling requirements for dangerous substances and preparations (Guidelines in Commission Directive 93/21/EEC), INTERMEDIO UB 2 does not have to be classified and has no obligatory labelling requirement for oral toxicity.